Publications by authors named "Reilly Coch"

Glucagon plays a central role in amino acid (AA) homeostasis. The dog is an established model of glucagon biology, and recently, metabolomic changes in people associated with glucagon infusions have been reported. Glucagon also has effects on the kidney; however, changes in urinary AA concentrations associated with glucagon remain under investigation.

View Article and Find Full Text PDF
Article Synopsis
  • GLP-1 is a hormone that helps insulin secretion and is usually produced by gut L cells, but α cells can also produce it under certain conditions.
  • The study shows that the GLP-1 receptor agonist liraglutide boosts GLP-1 production in α cells, dependent on β cell GLP-1 receptors.
  • Using a new technology called DART-Seq, researchers identified that liraglutide increased the expression of genes in a specific group of α cells, potentially revealing new pathways for diabetes treatment.
View Article and Find Full Text PDF

Glucagon is classically described as a counterregulatory hormone that plays an essential role in the protection against hypoglycemia. In addition to its role in the regulation of glucose metabolism, glucagon has been described to promote ketosis in the fasted state. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a new class of glucose-lowering drugs that act primarily in the kidney, but some reports have described direct effects of SGLT2i on α-cells to stimulate glucagon secretion.

View Article and Find Full Text PDF

Glucagon and insulin are commonly believed to have counteracting effects on blood glucose levels. However, recent studies have demonstrated that glucagon has a physiologic role to activate β-cells and enhance insulin secretion. To date, the actions of glucagon have been studied mostly in fasting or hypoglycemic states, yet it is clear that mixed-nutrient meals elicit secretion of both glucagon and insulin, suggesting that glucagon also contributes to glucose regulation in the postprandial state.

View Article and Find Full Text PDF

Paracrine interactions between pancreatic islet cells have been proposed as a mechanism to regulate hormone secretion and glucose homeostasis. Here, we demonstrate the importance of proglucagon-derived peptides (PGDPs) for α to β cell communication and control of insulin secretion. Signaling through this system occurs through both the glucagon-like peptide receptor (Glp1r) and glucagon receptor (Gcgr).

View Article and Find Full Text PDF